Michael McLinden - Partner
is the Strategy and Planning half of the Mc|K partnership.
For 9 years before starting Mc|K, he headed up the Planning and Market Strategies group for the Boston office of Lowe Healthcare, the world's third-largest medical marketing agency.
In 2001, he was appointed Managing Director of the Boston practice.
During that time, he worked throughout the Lowe Healthcare group as a specialist in new technologies including drug delivery, devices and diagnostics.
played a central role in the launch and relaunch of more than 2 dozen new technologies including drug-eluting stents, GERD repair, orthopedics, incontinence, and prostate cancer.
He is a specialist in biotechnology and bioprocessing, having worked on some of the world's first DNA sequencing and synthesis technology, and at all levels of drug discovery and development for biotech companies.
In traditional pharmaceuticals, Michael
has worked with a wide variety of brand-name drugs including those for seasonal rhinitis, migraine, AIDS wasting, bladder cancer, pancreatic cancer, cough and cold, resistant cough, and irritable bowel syndrome.
With all of his
"high-science" credentials, it may be surprising to learn that Michael
advertising career and received much of his
training in strategy and positioning with the consumer hot shop of Mintz & Hoke